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338Background:Long-term outcomes of repair of tetralogy of Fallot associated with complete atrioventricular sep-
tal defect are seldom reported. We report our survival and reintervention outcomes over a 29-year time period.
Methods:BetweenMarch 1979 and April 2008, 61 patients with the combined cardiac defect of atrioventricular
septal defect and tetralogy of Fallot were surgically managed. Trisomy 21 was present in 49 (80%) patients.
Primary repair was performed in 36 patients at a median age of 9 months (range, 1 month to 16 years), whereas
25 patients had initial palliation by systemic–pulmonary shunt at a median age of 21 months (range, 0 days to
36 years). Thirty-one (51%) patients had a transannular patch. Fifty-three patients required right ventriculotomy
for relief of the right ventricular outflow tract obstruction. Four patients had a right ventricle–pulmonary artery
conduit with a homograft. Relationships between patient characteristics and outcome variables were examined
using Kaplan-Meier survival curves; comparisons were performed using the log–rank test.
Results: Median follow-up was 4.7 years. A total of 12 patients died during the course of follow-up: 4 (7%)
deaths within 30 days of surgery and 8 late deaths (range, 4 months to 9.9 years after repair). Since 2000, there
have been no early deaths and 1 late death, 5 months after the operation. The estimated survival at 5 years after
definitive repair was 82% (95% confidence interval, 69%, 90%). Time to death was not associated with any
patient or surgical variables examined. Overall, 30% of the survivors required a reoperation. The type of reop-
erations was on the mitral valve (4 repairs, 4 replacements) and 7 pulmonary valve replacements. We did not find
an effect of era on mortality (P¼ .23 for comparison of 1979-1989, 1990-1999, and 2000-2008). The percentage
of patients with primary repair did not change during the different quartiles. The estimated freedom from reop-
eration at 5 years was 80% (65%, 90%). Time to reoperation was shorter for patients with a conduit (P ¼ .01).
Conclusions: Excellent long-term survival was achieved after repair of tetralogy of Fallot associated with com-
plete atrioventricular septal defect. Palliation and primary repair resulted in comparable outcomes; as such, pri-
mary repair is favored. The choice of right ventricular outflow tract reconstruction affects the need for
reoperation. (J Thorac Cardiovasc Surg 2012;143:338-43)The incidence of tetralogy of Fallot (TOF) with complete
atrioventricular septal defect (AVSD) lies around 6% to
16%.1,2 Outcomes among patients with TOF and AVSD
have improved since this condition was first corrected in
the 1970s.3 Since then, primary anatomic repair has be-
come more widely adopted, achieving mortality rates
lower than 5%.4,5 Although a number of reports about
the surgical management of this lesion are shared in the
literature, reports on long-term outcome after staged (pal-
liation followed by repair) and primary anatomic repair
are limited.e Departments of Cardiovascular Surgerya and Cardiology,b Children’s Hos-
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The Journal of Thoracic and Cardiovascular SurgWe evaluated our 29-year experience with complete cor-
rection of the combined lesion of TOF and AVSD and report
our outcomes.METHODS
Patients
Between March 1979 and April 2008, we identified patients with the
combined cardiac defect of AVSD and TOF who were surgically managed
at Children’s Hospital Boston. Individuals with unbalanced AVSDs requir-
ing single ventricle palliation and those with atrioventricular or ventricu-
loarterial discordance were excluded. Patient data were collected from
inpatient and outpatient medical records, operative lists, cardiac surgery
registry, echocardiography, and other interventional reports. Follow-up
data were obtained from the notes of the most recent visit or intervention
here at Children Hospital Boston. The Institutional Review Board at Chil-
dren’s Hospital Boston approved the study.
Surgical Management
The approach to the patient with combinedAVSD and TOFover the past
3 decades has changed. Whereas surgical correction after a period of pal-
liation with a systemic–pulmonary shunt was the initial surgical approach,
primary anatomic repair has gained favor. In this cohort, all lesions were
repaired with hypothermic (25C-33C) cardiopulmonary bypass with
(n ¼ 8) or without (n ¼ 53) circulatory arrest.ery c February 2012
TABLE 1. Patient and surgical characteristics
No. (%) or median (range)
Gender
Male 25 (41%)
Female 36 (59%)
Trisomy 21 49 (80%)
Prematurity 4 (6%)
Age at definitive operation (y) 1.2 (0–36.9)
Indication for operation
Cyanosis 27 (44%)
Hypercyanotic spell 18 (29%)
CHF and cyanotic spell 1 (2%)
Elective repair 4 (6%)
Type of first operation
Palliative 25 (41%)
Complete 36 (59%)
If palliative (n ¼ 25):
BT shunt 22 (88%)
Central shunt 3 (12%)
Definitive AVSD surgery type
Single patch 38 (62%)
Double patch 20 (33%)
Modified (Australian repair) 3 (5%)
Conduit use 4 (7%)
Complete heart block 5 (8.2%)
TAP reconstruction
Done 31 (51%)
Not done 30 (49%)
If TAP not done (n ¼ 30):
Infundibular patch 22 (73%)
No infundibular patch 8 (27%)
Rastelli
A 1 (2%)
B 0 (0%)
C 56 (92%)
Unknown 4 (6%)
Abbreviations and Acronyms
AVSD ¼ atrioventricular septal defect
CI ¼ confidence interval
TAP ¼ transannular patch
TOF ¼ tetralogy of Fallot
VSD ¼ ventricular septal defect
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DCrystalloid (n ¼ 34) or blood cardioplegia (n ¼ 27) was used for myo-
cardial protection. One of 3 surgical techniques was adopted for repair of
the AVSD: single-patch repair (n ¼ 38), 2-patch repair (n ¼ 20), and mod-
ified single-patch repair technique (n ¼ 3). The choice was based on the
surgeon’s discretion and individual heart anatomy. The zone of apposition
in the left atrioventricular valve was routinely closed unless there was an
increased risk of left atrioventricular valve stenosis.
Repair of TOF included the relief of the right ventricular outflow tract
obstruction, which was achieved in most cases via an infundibular incision,
and resection of obstructive right ventricular muscle bundles. If the pulmo-
nary valve diameter Z score was less than2.0, a transannular repair was
performed.
We defined a transannular patch (TAP) repair as an incision that tra-
verses the ventriculopulmonary junction and placement of pericardial or
polytetrafluoroethylene patch (Gore-Tex patch; W. L. Gore & Associates,
Inc, Flagstaff, Ariz) across. Indications for use of homograft or valved con-
duit included aberrant left anterior descending artery crossing the right ven-
tricular outflow tract and infundibulum. When TAP repair was performed,
free pulmonary regurgitation was experienced.
Statistical Analysis
Patient characteristics were summarized using number (percent) for cat-
egorical variables and median (range) for continuous variables. Primary
outcome variables were time from definitive repair to death and time
from definitive repair to reoperation. Patients not experiencing an outcome
were censored at their time of last follow-up. Relationships between patient
characteristics and outcome variables were examined using Kaplan-Meier
survival curves; comparisons were performed using the log–rank test.Year of operation
1979–1989 18 (30%)
1990–1999 21 (34%)
2000–2008 22 (36%)
CHF,Congestive heart failure; BT,Blalock-Taussig; AVSD, atrioventricular septal de-
fect; TAP, transannular patch.RESULTS
Patient and Surgical Characteristics
A total of 61 patients underwent repair of both TOF and
complete AVSD. Trisomy 21 was present in 49 (80%) pa-
tients. Only 4 (6%) patients were premature. Associated
cardiac diagnoses included left superior vena cava (n ¼ 9)
and an aberrant left anterior descending artery (n ¼ 2).
Nearly half of the patients were cyanotic at the time of sur-
gery (44%) (Table 1). Other surgical procedures were also
performed when necessary; these procedures are listed in
Table 2.
Primary repair was performed in 36 patients at a median
age of 9 months (range, 1 month to 16 years), whereas 25
patients had initial palliation by systemic–pulmonary shunt
at a median age of 21 months (range, 0 days to 36 years). All
zones of appositions were approximated at the primary in-
tracardiac operation except in the presence of a hypoplastic
left atrioventricular valve (n ¼ 2) or double orifice valve
(n ¼ 2) that might result in a stenotic orifice.The Journal of Thoracic and CaThe need for a TAP was based on the size of the pul-
monary valve annulus on inspection as well as Hagar di-
lation; 31 (51%) patients had a TAP. The remaining 30
patients did not require a TAP; in 8 the repair was done
via a transatrial and transpulmonary approach, 4 required
a homograft conduit, and the others also required a right
ventriculotomy.Patient Outcomes
Median follow-up was 4.7 years. A total of 12 patients
died during the course of follow-up, 4 within 30 days of
surgery, and 8 late deaths more than 30 days after surgery
(range, 4 months to 9.9 years). Poor cardiac functionrdiovascular Surgery c Volume 143, Number 2 339
TABLE 2. Associated cardiac procedures and other cardiac and
medical conditions in patients undergoing repair of TOF-AVSD
(n ¼ 61)
TOFAVC
Associated procedures
Mitral valve annuloplasty 5
Splitting of the single papillary muscle 3
Baffle left superior vena cava to right atrium 2
Fenestrated VSD (3 mm) 1
Fenestrated ASD 10
Monocusp pericardial pulmonary valve 1
Takedown of Fontan conduit 1
Total anomalous pulmonary venous drainage
repair (supracardiac)
1
Associated conditions
Absent pulmonary valve–TOF 1
Right dominant AVSD, single papillary muscle. 1
Dandy-Walker syndrome 1
DeLange syndrome 1
Craniosynostosis 1
Unbalanced AVC
Right dominant 2
Left dominant 2
Medical hypothyroidism 2
TOF, Tetralogy of Fallot; AVSD, atrioventricular septal defect; AVC, atrioventricular
canal; VSD, ventricular septal defect; ASD, atrial septal defect.
FIGURE 1. Kaplan-Meier curve illustrates the probability of survival af-
ter definitive repair.
FIGURE 2. Kaplan-Meier curve illustrates freedom from cardiac reoper-
ation after definitive repair.
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Dassociated with multiorgan failure and sepsis were the ma-
jor causes of early death. One patient was referred to our
center for complete repair at age 16 years after modified
Blalock-Taussig shunt done elsewhere and severe cyano-
sis. Right heart catheterization after repair revealed
a high pulmonary vascular resistance of 4.8 Wood units
with a patent foramen ovale, a mean pulmonary artery
pressure 30 mm Hg, and severe left atrial hypertension
with severe mitral regurgitation requiring mitral valve
replacement; this patient could not be weaned from car-
diopulmonary bypass. The others, despite technically
competent anatomic repair and lack of hemodynamic re-
sidual defects, died of a combination of low cardiac output
in isolation for unknown reasons or of multiorgan failure.
Among the 4 early deaths, 3 patients had a TAP and 2 had
a right ventricle–pulmonary artery conduit. Also, 3 had
single-patch and 1 had 2-patch repair. One patient had
a complete heart block requiring pacemaker connection;
this patient was taken back for a bidirectional Glenn
procedure.
The causes of late death were not available. Since 2000,
there have been no early deaths and only 1 late death
(5 months after repair). Estimated survival at 1 year after de-
finitive repair was 86% (95% confidence interval [CI],
75%, 93%), and estimated 5-year survival 82% (95%
CI, 69%, 90%; Figure 1). Percentages of patients with pri-
mary repair are 56% in 1979-1989, 67% in 1990-1999, and
55% in 2000-2008.340 The Journal of Thoracic and Cardiovascular SurgSeventeen patients required cardiac reoperations: 4 mi-
tral valve repairs, 5 mitral valve replacements, and 7 pulmo-
nary valve replacements (4 homograft conduits and 3
Carpentier-Edwards valve conduits [Edwards Lifesciences,
Irvine, Calif]). Estimated freedom from reoperation at 1
year after repair was 89% (95% CI, 77%, 95%), and esti-
mated freedom from reoperation at 5 years was 80% (95%
CI, 65%, 90%) (Figure 2).
The mitral valve repairs encompassed closure of the re-
sidual mitral valve zone of apposition (n ¼ 4) and patch
augmentation of the anterior bridging leaflets (n ¼ 1).
When mitral repair was not feasible, mechanical valve re-
placement was performed. Two patients required valve re-
placement at the same surgical procedure and 3 patients
required mitral valve replacement within a few days after
primary repair owing to persistent mitral valve regurgita-
tion. Among the patients who had mitral valve replacement,
only 1 patient had rereplacement of the mitral valve from
the time of the definitive repair.ery c February 2012
TABLE 3. Right ventricular nonquantitative function at last
echocardiographic imaging function
Normal function 6 (9.8%)
Mild dysfunction 27 (44.3%)
Moderate 13 (21.3%)
Severe 4 (6.6%)
Not assessed and missing 11 (18.1%)
TABLE 5. Univariate relationships between patient and operative
variables and time to reoperation
P value
Gender .44
Trisomy 21 .53
Age at definitive operation (<6 mo, 6-11.9 mo,
1-2.9 y,  3 y)
.77
Type of first operation (complete, palliative) .09
Conduit use .01
TAP reconstruction .13
If TAP not done, infundibular patch .27
Year of operation (1979-1989, 1990-1999,
2000-2008)
.27
P values calculated by log–rank test. Patients with a conduit had a statistically signif-
icant shorter time to reoperation than those without a conduit. TAP, Transannular
patch.
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rare; there was only 1 patient with heterotaxy TOF–AVSD
Rastelli A reoperation for tricuspid valvuloplasty as well
as resection of supramitral ring and suboaortic membrane
5 years later.
Finally, we reviewed right ventricular function based on
echocardiographic reports at last follow-up. Table 3 shows
that most patients fell into the category of mild to moderate
right ventricular dysfunction. Few patients had severe ven-
tricular dysfunction long-term. When ventricular function
was stratified to ventriculotomy (n ¼ 53) versus transat-
rial–transpulmonary repair (n ¼ 8), there were no statisti-
cally significant differences (P ¼ .24).
Relationships Between Patient Characteristics and
Outcomes
In this cohort of patients, time to death was not signif-
icantly associated with era of repair (1979-1989, 1990-
1999, 2000-2008), gender, trisomy 21, initial primary
repair versus palliation, age at definitive repair, type of
operation including conduit use, or TAP reconstruction
(Table 4).
Time from repair to reoperation was not significantly as-
sociated with era of repair, gender, trisomy 21, primary re-
pair versus palliation at initial surgery, age at repair, type of
surgery, or TAP reconstruction (Table 5). However, time to
reoperation was shorter for patients with a conduit (P¼ .01,
Figure 3).TABLE 4. Univariate relationships between patient and operative
variables and time to death
P value*
Gender .48
Trisomy 21 .12
Age at definitive operation (<6 mo, 6-11.9 mo,
1-2.9 y,  3 y)
.09
Type of first operation (complete, palliative) .87
Type of definitive AVSD operation (single
patch, double patch, modified)
.84
Conduit use .95
TAP reconstruction .95
If TAP not done, infundibular patch .35
Year of operation (1979-1989, 1990-1999,
2000-2008)
.24
AVSD, Atrioventricular septal defect; TAP, transannular patch. *P values calculated
by log–rank test.
The Journal of Thoracic and CaAlso, percentages of patients with primary repair were
56% in 1979-1989, 67% in 1990-1999, and 55% in
2000-2008. Differences were not statistically significant.
All 4 of the early deaths were during the middle time period,
1990-1999. For the 8 late deaths, 5 were in the first time pe-
riod, 2 in the second, and 1 in the last. However, this differ-
ence is not statistically significant.DISCUSSION
The presentation of both TOF and AVSD is a widely rec-
ognized congenital heart defect combination. TOF is com-
monly associated with trisomy 21.6-8 Similar to other
series, the presence of trisomy 21 in our study was not
associated with either worse survival or increased risk of
reintervention.9
Overall, contemporary awareness of this improved peri-
operative management as reported in the literature has re-
duced mortality rates from the earlier 29% to 40% to the
current 0% to 11% over the past 20 years.10,11 However,
in our study we did not find an effect of era on mortalityFIGURE 3. Kaplan-Meier curve illustrates freedom from cardiac reoper-
ation after definitive repair, by conduit use (P ¼ .01, log–rank test).
rdiovascular Surgery c Volume 143, Number 2 341
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2000-2008). Nonetheless, there were only 12 deaths total
and therefore we do not have enough statistical power to
say that mortality has not changed over time. In fact,
there was only 1 death in the 2000-2008 time period; it is
possible that with a larger sample size or additional
follow-up we could find a statistically significant difference.
A pathognomic anatomic feature of this lesion is defi-
ciency of the atrioventricular portion of the interventricu-
lar septum as in isolated AVSD with inlet and outlet
ventricular septal defect (VSD) extending to the conflu-
ence of the superior bridging leaflet toward the aortic
valve. The most common type of AVSD associated with
TOF is type C Rastelli.10-12 In addition, the conal
septum has an anterior and superior displacement
compared with the rest of the interventricular septum.
Although the classic manifestation of this combined
lesion is cyanosis (60% in our study), the untreated
natural history more closely resembles right ventricular
outflow tract obstruction than AVSD as such. At the
extreme end of the spectrum, cyanosis combined with
heart failure related to severe atrioventricular valve
insufficiency is challenging but rare. Only 2 patients had
moderate to severe preoperative left atrioventricular
valve insufficiency that required mitral annuloplasty in
addition to zone of apposition closure.
Cyanosis develops toward the end of infancy in most
children. As is the case with TOF, the age at clinical pre-
sentation depends on the degree of right ventricular out-
flow tract obstruction (typically greater than a peak
gradient>35 mm Hg) or severity of atrioventricular valve
regurgitation at presentation.13 Either palliation with a sys-
temic shunt or complete anatomic repair can alleviate the
cyanosis. Also, palliation with a shunt can increase the
end-diastolic volume of the ventricle with potential for ex-
acerbating atrioventricular valve regurgitation. With our
growing experience, we adopt palliation when the child
is at high risk for cardiac dysfunction such as severe ven-
tricular hypertrophy or other medical comorbidities when
the long-term prognosis is poor. We found no difference in
survival after palliation compared with primary repair of
TOF–AVSD.
On the basis of these data, our current approach is to per-
form primary anatomic repair within the first year of life or
in any symptomatic patient. Our experience is in agreement
with that of the University of California at San Francisco
group. McElhinney and associates14 reported on 9 patients
who had complete anatomic repair of combined TOF–
AVSD among an age group between 2.5 and 16 months.
Repair of the atrioventricular outflow tract included infun-
dibular myomectomy in 8, pulmonary valvotomy in 2,
and use of a right ventricle–pulmonary artery allograft con-
duit in 2. They14 reported no early mortality but they did not
report no reoperative events given their limited follow-up.342 The Journal of Thoracic and Cardiovascular SurgAppreciation that the aorta is rightward to an even greater
extent than in TOF given that the aorta is also unwedged
is important at the time of surgical repair. Adequate expo-
sure of the VSD and assurance that the VSD patch is appro-
priately contoured to avoid right or left outflow tract
obstruction is necessary. Suturing the ventricular compo-
nent of the patch is usually made easier with right ventric-
ular infundibular incision. Competency of the right and
left atrioventricular valves is also important, especially in
the presence of an incompetent pulmonary valve, and in
such instances right ventricle–pulmonary valved conduits
(eg, pulmonary or aortic homografts or xenografts) should
be strongly considered.15 However, use of conduits early
in infancy is a strong risk factor for reoperation.
The choice of repair of AVSD spanned a number of years,
and operations were performed by many different surgeons.
Historically, we adopted the single-patch technique; the
2-patch and most recently the modified single-patch tech-
nique further overlapped this. The latter was used in only
3 patients and they all survived long-term, requiring no fur-
ther reintervention. Left ventricular outflow tract obstruc-
tion is a potential complication at the time of VSD
closure.16 The VSD closure technique is critical to allow
an unobstructed left ventricular outflow tract and is gener-
ally achieved with redundancy of the anterior part of the
VSD patch. Others and we have not witnessed any new-
onset left ventricular outflow tract obstruction.17,18
However, our experience with a modified single-patch tech-
nique in TOF–AVSD is very limited and a robust conclusion
and recommendation cannot be provided.
Although there have been several reports of TOF–AVSD
from centers around the world,19,20 they each comprise no
more than 35 patients. To our knowledge, our study
reports one of the largest cohorts with long-term follow-up.
The type of right ventricular surgical intervention did not
affect survival. Our findings are in agreement with those of
Brancaccio and colleagues.21 In a study of 33 children from
1992 to 2006, multivariable analysis showed that type of re-
lief of right ventricular outflow tract obstruction did not
influence survival, nor did the choice to use a right ventri-
cle–pulmonary artery valved conduit. A total of 4 patients
died after surgery, 3 in our early experience. The causes
of death were progressive heart failure in 2 patients and
multiple organ failure in the other 2. Others have reported
similar etiologies as well. Prifti and associates,19 in a study
of 17 patients with TOF with AVSD, had a 17.6% early mo-
rality owing to multiorgan and heart failure. Survival at 5
years after definitive repair was 82% (95% CI, 69%,
90%). Time to death was not associated with any particular
variable. Sixteen patients required reoperation (7 pulmo-
nary valve replacements and 9 mitral valve reinterventions).
The estimated freedom from reoperation at 5 years was
80% (95% CI, 65%, 90%). However, time to reoperation
was shorter for patients with a conduit (P ¼ .01).19ery c February 2012
Shuhaiber et al Congenital Heart Disease
C
H
DReinterventions after TOF–AVSD include surgery of the
left atrioventricular valve (repair or replacement) as well as
repair of either residual or recurrent right outflow tract. Re-
sidual VSD or atrial septal defect was also closed at this
time.
Placement of a right ventricle–pulmonary artery conduit
was associated with significantly increased risk for reinter-
vention. In a study by Prifti and associates,19 mean age at re-
pair was 2.9 years and mean gradient across the right
ventricular outflow tract was 63 mmHg. All underwent clo-
sure with a single patch. Six (35%) patients required a TAP.
There were 3 (17%) hospital deaths during a mean follow-
up of 36  34 months. At long-term follow-up, 2 patients
required late reoperation owing to severe left atrioventricu-
lar valve regurgitation at 8.5 months and 21 months.
At the time of definitive repair, 2 patients in our series had
significant left atrioventricular valve regurgitation requiring
mitral valve replacement when the AVSD component of the
TOF-AVSD was repaired. One patient died and the other
survived, despite heart block. Both of these patients were
early in our experience. Both had single-patch repair of
AVSD. The remaining patients (n ¼ 59) had repair of left
atrioventricular valve by closure of the residual zone of ap-
position with or without annuloplasty.
Although the number of patients in this cohort is the larg-
est yet reported, it remains a relatively small sample size
with which to identify robust associations, owing to the
small number of outcome events. It is possible that our find-
ings could be confounded by patient selection and clinical
decision making inasmuch as it is a retrospective study
and not a prospective randomized trial comparing more
than one management strategy.
In conclusion, survival after primary repair of TOF asso-
ciated with complete AVSD is similar to that of palliation
followed by repair. Use of a TAP across the right ventricular
outflow tract is safe and minimized risk of reintervention
long-term.
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